PPC vs. MED, HSY, K, GIS, TSN, MKC, HRL, SJM, SFD, and CPB
Should you be buying Pilgrim's Pride stock or one of its competitors? The main competitors of Pilgrim's Pride include MEDIFAST (MED), Hershey (HSY), Kellanova (K), General Mills (GIS), Tyson Foods (TSN), McCormick & Company, Incorporated (MKC), Hormel Foods (HRL), J. M. Smucker (SJM), Smithfield Foods (SFD), and Campbell's (CPB).
Pilgrim's Pride vs. Its Competitors
Medifast (NYSE:MED) and Pilgrim's Pride (NASDAQ:PPC) are both consumer staples companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, risk, media sentiment, valuation, dividends and profitability.
Medifast currently has a consensus price target of $16.50, suggesting a potential upside of 25.09%. Pilgrim's Pride has a consensus price target of $49.00, suggesting a potential upside of 2.15%. Given Medifast's higher probable upside, equities analysts clearly believe Medifast is more favorable than Pilgrim's Pride.
Medifast has a beta of 0.8, suggesting that its stock price is 20% less volatile than the S&P 500. Comparatively, Pilgrim's Pride has a beta of 0.5, suggesting that its stock price is 50% less volatile than the S&P 500.
In the previous week, Pilgrim's Pride had 2 more articles in the media than Medifast. MarketBeat recorded 7 mentions for Pilgrim's Pride and 5 mentions for Medifast. Pilgrim's Pride's average media sentiment score of 1.31 beat Medifast's score of 0.12 indicating that Pilgrim's Pride is being referred to more favorably in the news media.
95.5% of Medifast shares are held by institutional investors. Comparatively, 16.6% of Pilgrim's Pride shares are held by institutional investors. 2.9% of Medifast shares are held by company insiders. Comparatively, 82.6% of Pilgrim's Pride shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Pilgrim's Pride has a net margin of 6.81% compared to Medifast's net margin of 0.76%. Pilgrim's Pride's return on equity of 37.15% beat Medifast's return on equity.
Pilgrim's Pride has higher revenue and earnings than Medifast. Pilgrim's Pride is trading at a lower price-to-earnings ratio than Medifast, indicating that it is currently the more affordable of the two stocks.
Summary
Pilgrim's Pride beats Medifast on 12 of the 16 factors compared between the two stocks.
Get Pilgrim's Pride News Delivered to You Automatically
Sign up to receive the latest news and ratings for PPC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding PPC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Pilgrim's Pride Competitors List
Related Companies and Tools
This page (NASDAQ:PPC) was last updated on 8/16/2025 by MarketBeat.com Staff
MarketBeat All Access